Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metolazone in acute decompensated heart failure
NCT05633758Phase 2Withdrawn
- Sponsor
- Scripps Health
- Start
- Mar 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metolazone in heart failure (HF), sponsored by Scripps Health. Planned start Mar 2014; status: withdrawn.
02
Drugs
metolazone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05633758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05633758.